Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This study is designed to provide short term efficacy and safety data of TRI476 in children
with inadequately-controlled partial seizures. Patients will be randomized into either drug
treatment or placebo group at 1:1 ratio, and receive their respective treatment for 8 weeks.
The purpose of study is to confirm that TRI476 as adjunctive therapy is effective and safe.